甲状腺相关眼病眶内免疫微环境与Th17细胞通路研究
本研究通过单细胞测序和流式细胞术分析甲状腺相关眼病(TAO)患者眶内结缔组织,发现TAO眶内微环境以Th17和Th2细胞反应为特征,Th17通路相关因子与TAO及临床活动度相关,CD34+眶成纤维细胞通过前列腺素E2-EP2/EP4-cAMP信号促进Th17表型。
要点
- TAO眶内微环境存在Th17和Th2细胞反应,Th17细胞呈Th1样表型。
- Th17通路因子(IL-17A、IFN-γ、RORγt、IL-23R、IL-21R)与TAO相关。
- CD34+眶成纤维细胞通过PGE2-EP2/EP4-cAMP信号促进Th17表型。
核心结论
- TAO眶内免疫微环境以Th17和Th2细胞反应为特征,Th17通路参与TAO发病。
研究设计与样本
- 收集TAO和对照眶结缔组织,采用单细胞测序、多色流式细胞术、体外模型、共培养实验和蛋白质印迹分析。
主要发现
- TAO眶内微环境由自然杀伤细胞、树突状细胞、巨噬细胞、T细胞、浆细胞和CD34+眶成纤维细胞组成,B细胞少。
- TAO眶内CD3+CD8- IL-17A产生和RORγt表达T细胞增加,CD3+CD8- IL-13产生和GATA3表达T细胞增加。
- TAO眶内Th17细胞表达更高IL-23R和IL-1R,更低IL-21R,并存在IFN-γ产生和RORγt+Tbet+ T细胞。
- 多因素分析显示Th17通路[IL-17A(P=0.001)、IFN-γ(P=0.009)、RORγt(P=0.003)、IL-23R(P=0.033)、IL-21R(P=0.019)]和Th2通路[IL-13(P=0.015)、GATA3(P=0.012)]与TAO相关。
- IL-17A、IL-23R和IL-1R与临床活动度评分和视力相关。
临床怎么用
- 眶内Th17通路可能作为TAO发病机制干预的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Unique features of local immunity in thyroid-associated ophthalmopathy (TAO) may affect disease progression. OBJECTIVE: To investigate the association between the orbital immune microenvironment and TAO development. DESIGN/SETTING/PARTICIPANTS: TAO and control orbital connective tissues were collected. MAIN OUTCOME MEASURES: Single-cell sequencing examined orbital lymphocytic infiltrates. Multicolor flow cytometry explored the phenotypes of different cell subsets and in vitro models for cell functional studies. Coculture experiment and western blotting assay were used to determine underlying mechanism of the enhanced T helper 17 (Th17) cell pathway. RESULTS: The TAO orbital microenvironment was composed of natural killer cells, dendritic cells, macrophages, T cells, plasma cells, and CD34+ orbital fibroblasts, but few B cells. Increases in CD3+CD8- IL-17A-producing and RAR-related orphan receptor (ROR)γt-expressing T cells and in CD3+CD8- IL-13-producing and GATA3-expressing T cells suggested Th17 and Th2 cell responses in TAO orbits. Increased interferon-γ (IFN-γ)-producing and RORγt+Tbet+ T cells indicated a Th1-like phenotype of orbital-infiltrating Th17 cells. Higher IL-23R and IL-1R expression and lower IL-21R expression were also observed on Th17 cells in TAO orbits. Multivariate analyses revealed that the Th17 pathway [IL-17A (P = 0.001), IFN-γ (P = 0.009), RORγt (P = 0.003), IL-23R (P = 0.033), IL-21R (P = 0.019)], and Th2 pathway [IL-13 (P = 0.015), GATA3 (P = 0.012)] were associated with TAO. IL-17A, IL-23R, and IL-1R correlated with clinical activity score and visual acuity. CD34+ orbital fibroblasts exhibited distinct cell surface marker expression and promoted IL-23R and IL-1R expression on T cells to facilitate the Th17-cell phenotype through prostaglandin E2-EP2/EP4-cAMP signaling. CONCLUSION: Our study addresses the importance of retroorbital immunity and suggests possible means of disrupting TAO pathogenesis.
引用
- Fang S, Huang Y, Wang N, et al. Insights Into Local Orbital Immunity: Evidence for the Involvement of the Th17 Cell Pathway in Thyroid-Associated Ophthalmopathy. J Clin Endocrinol Metab. 2019. PMID: 30517642. doi:10.1210/jc.2018-01626
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。